|
UBQLN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.74520456051187E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5045964474325E-11 |
| Normal-vs-Stage2 |
4.163700E-03 |
| Normal-vs-Stage3 |
1.018790E-03 |
| Normal-vs-Stage4 |
1.804990E-01 |
| Stage1-vs-Stage2 |
3.278600E-01 |
| Stage1-vs-Stage3 |
2.336000E-01 |
| Stage1-vs-Stage4 |
3.083800E-01 |
| Stage2-vs-Stage3 |
9.602800E-01 |
| Stage2-vs-Stage4 |
7.917000E-01 |
| Stage3-vs-Stage4 |
8.011400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.3510976739708E-11 |
| Normal-vs-AfricanAmerican |
3.34600000040375E-07 |
| Normal-vs-Asian |
9.967500E-02 |
| Caucasian-vs-AfricanAmerican |
9.384200E-01 |
| Caucasian-vs-Asian |
7.771400E-01 |
| AfricanAmerican-vs-Asian |
7.494400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1756819396378E-12 |
| Normal-vs-Female |
2.636000E-03 |
| Male-vs-Female |
1.660190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.77249999999685E-06 |
| Normal-vs-Extreme_Weight |
1.32179822642797E-11 |
| Normal-vs-Obese |
2.407000E-04 |
| Normal-vs-Extreme_Obese |
3.384800E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.065200E-01 |
| Normal_Weight-vs-Obese |
2.400000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.435000E-01 |
| Extreme_Weight-vs-Obese |
5.078400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.349400E-01 |
| Obese-vs-Extreme_Obese |
3.821600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.008500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.71729999951265E-07 |
| Normal-vs-Age(61-80Yrs) |
6.8539618425234E-12 |
| Normal-vs-Age(81-100Yrs) |
8.48940000519605E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.586000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.516800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.040000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.332400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.222750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.511800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.77045094935147E-12 |
| Normal-VS-Type2 PRCC |
1.57929999999862E-06 |
| Normal-VS-KIRP CIMP |
9.450600E-01 |
| Normal-VS-Unclassified PRCC |
1.301010E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.144600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.920600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.465800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.684300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.147400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.621800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.71319999800568E-08 |
| Normal-vs-N1 |
1.344420E-01 |
| Normal-vs-N2 |
6.931800E-01 |
| N0-vs-N1 |
2.577900E-02 |
| N0-vs-N2 |
5.862600E-01 |
| N1-vs-N2 |
9.844600E-01 |
|
|
